What You Don’t Know About Drug Trials Can Hurt You (and Your Portfolio)
Biotech stocks are notoriously volatile; understanding how drugs are approved can help.
Related Articles
Time to Say Goodbye to the B.M.I.? (Gift Article)
The body mass index has long been criticized as a flawed indicator of health. A replacement has been gaining support: the body roundness index.
Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study
This is the longest follow-up study of children with SARS-CoV-2 infection, showing a significant and long-lasting burden of Long Covid in the pediatric population. Our…
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
Our recent study using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults, with meta-analytic…
What AI Can Do in Healthcare—and What It Should Never Do
Kaiser Permanente AI chief Daniel Yang is on the front line of deploying artificial intelligence as well as testing its bounds. “We did identify some…
Characteristics and predictors of Long Covid in children: a 3-year prospective cohort study
This is the longest follow-up study of children with SARS-CoV-2 infection, showing a significant and long-lasting burden of Long Covid in the pediatric population. Our…
mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity
Kenney et al. explore the therapeutic potential of an mRNA-delivered IDO1 that is modified to include a myristoylation sequence, which allows the protein to insert into…
A systems view of the vascular endothelium in health and disease
This review explores the crucial role of vascular endothelial cells in organ function and systemic health. It discusses the diverse functions of endothelial cells throughout…
Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis
Age is a major risk factor for cancer, but how aging impacts tumor control remains unclear. Here, we establish that aging of the immune system,…
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
Our recent study using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults, with meta-analytic…